Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-19-001063
Filing Date
2019-02-14
Accepted
2019-02-14 11:25:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 BENITEC BIOPHARMA LTD/ADR p19-0278sc13ga.htm SC 13G/A 69095
  Complete submission text file 0000902664-19-001063.txt   70745
Mailing Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019 2122874900
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

EIN.: 134131516 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 120 BROADWAY 32ND FLOOR NEW YORK NY 10271
Business Address 120 BROADWAY 32ND FLOOR NEW YORK NY 10271 212-238-3128
Benitec Biopharma LTD/ADR (Subject) CIK: 0001552795 (see all company filings)

EIN.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-88998 | Film No.: 19602852
SIC: 2834 Pharmaceutical Preparations